Fri.Dec 15, 2023

article thumbnail

Arcutis' Zoryve bags 2nd FDA nod, this time as a foam to treat 'the great neglected disease in dermatology'

Fierce Pharma

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK. | About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.

FDA 325
article thumbnail

Study suggests PBMs are gaming pharmacy system to overcharge for drugs

PharmaVoice

Markups for generics can be as high as 7,000%, the researchers said.

136
136
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

With new FDA approval, Merck's Welireg takes another step toward blockbuster goal

Fierce Pharma

Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. | Since Merck secured approval for kidney cancer pill and blockbuster hopeful Welireg (belzutifan) in August of 2021, sales have grown slowly but surely. With a second FDA nod for a much larger patient population, the company can anticipate a more pronounced upswing in revenue from the hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor.

FDA 306
article thumbnail

WeightWatchers Launches New GLP-1 Support Program

MedCity News

WeightWatchers’ new GLP-1 program offers daily nutritional and activity targets, recommended foods, recipes, food and activity tracking, a digital community, virtual workshops and access to coaches 24/7.

Food 134
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Activist shareholders urge drugmakers to re-evaluate patent strategies, human rights policies

Fierce Pharma

Over the years, shareholders at the Interfaith Center on Corporate Responsibility (ICCR) have repeatedly voiced concerns on a variety of subjects to top pharma companies. | Once again, shareholders with the Interfaith Center on Corporate Responsibility are raising access concerns in proposals to several top drugmakers.

Pharma 195
article thumbnail

Navigating the Telehealth Surge: Prioritizing Quality and Continuity of Care

MedCity News

By prioritizing patient care and adapting our business models to meet the demands of our patients, we can ensure that the telehealth industry continues to provide meaningful and lasting benefits to all those who need it.

Patients 122

More Trending

article thumbnail

Building Trust in AI: Why All Health Organizations Need a Plan To Address AI Bias

MedCity News

To harness the best parts of AI — and avoid its worst possible outcomes — you need an AI strategy that not only includes technical implementation tactics but also prioritizes efforts to minimize bias, address ethical considerations, and build consumer trust and confidence.

Ethics 120
article thumbnail

MSD claims 2nd FDA approval for Welireg, in kidney cancer

pharmaphorum

MSD claims 2nd FDA approval for Welireg, in kidney cancer Phil.

FDA 115
article thumbnail

StartUPDATES: New Developments for Healthcare Startups

MedCity News

This week, check out news from Alpha Sophia, Encellin, CalmWave, Essential AI, and MATTER.

article thumbnail

Positive results for mRNA vaccine in melanoma patients

European Pharmaceutical Review

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. The randomised study, KEYNOTE-942, evaluated the treatment in patients with high-risk stage III/IV melanoma. Analysis shows that after three years, treatment with mRNA-4157 (V940) in combination with checkpoint inhibitor Keytruda reduced the risk of recurrence or death by 49 percent compared w

Patients 115
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New filtering system to combat spread of infections in hospitals

PharmaTimes

The combined system works to detect and eliminate airborne pathogens - News - PharmaTimes

111
111
article thumbnail

How AI Scribe Vendors Can Better Meet the Needs of Primary Care Physicians

MedCity News

Elation Health released results of a survey it conducted to learn more about how primary care physicians feel about AI scribes. It found that they haven’t really experienced the benefits of these tools yet, but they hope AI scribes can lead to time savings, reduced cognitive burden, improved job satisfaction, better patient focus and more time for care coordination.

article thumbnail

CHMP issues positive option for first gene-editing medicine

European Pharmaceutical Review

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the conditional approval of Vertex’s gene-editing therapy Casgevy for the treatment of severe sickle cell disease and transfusion-dependent beta thalassemia. Casgevy (exagamglogene autotemcel) is a CRISPR/Cas9 gene-edited cell therapy.

Medicine 110
article thumbnail

Enrolment starts in trial of AI-powered Parkinson’s therapy

pharmaphorum

Enrolment starts in trial of AI-powered Parkinson’s therapy Phil.

109
109
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Tech Literacy: A Cornerstone of Preventive Care for Older Adults

MedCity News

As we advocate for healthier aging, proficiency in technology emerges as not just an optional skill, but as a fundamental pillar of holistic healthcare for older adults.

article thumbnail

AstriVax awarded €3m to develop therapeutic vaccine for hepatitis B

PharmaTimes

The funding builds on AstriVax’s €30m in seed funding for its vaccine platform - News - PharmaTimes

108
108
article thumbnail

NICE’s new cholesterol guidance looks beyond statins

pharmaphorum

NICE’s new cholesterol guidance looks beyond statins Phil.

107
107
article thumbnail

Alkermes to sell Irish manufacturing facility to Novo Nordisk

European Pharmaceutical Review

Alkermes has agreed to sell its pharmaceutical development and manufacturing facility in Athlone, Ireland to Novo Nordisk for $92.5 million. “The acquisition of the Athlone facility represents an expansion of Novo Nordisk’s global manufacturing setup and will provide Novo Nordisk with additional development and manufacturing capacity for current and future oral products,” commented Thilde G.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

CDC Raises Urgent Alert for Low Vaccination Coverage for COVID-19, Influenza, RSV

PharmExec

CDC data show hospitalizations among all age groups spiked by 200% for influenza, 51% for COVID-19, and 60% for respiratory syncytial virus over the past four weeks, emphasizing the need for improved outreach efforts among at-risk populations.

98
article thumbnail

AstriVax awarded €3m to develop therapeutic vaccine for hepatitis B

PharmaTimes

The funding builds on AstriVax’s €30m in seed funding for its vaccine platform AstriVax has announced that it has been awarded a total of €3m in funding from Flanders Innovation & Entrepreneurship (VLAIO) for its therapeutic vaccine targeting chronic hepatitis B. The new funding will bring the company closer to revolutionising therapeutic vaccine development and creating a long-lasting impact in the hepatitis B field.

article thumbnail

FDA Approves Padcev/Keytruda Combo for Locally Advanced, Metastatic Urothelial Cancer

PharmExec

In clinical trials, Padcev (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) produced a statistically significant improvement in survival compared to platinum-based chemotherapy alone in patients with locally advanced or metastatic urothelial cancer.

FDA 98
article thumbnail

Study: Stem Cell Therapy Shows Improvement in QoL for Those With Heart Failure

Pharmacy Times

Investigators also found that the results demonstrated lower death and hospitalization rates for those with advanced heart failure treated with cell therapy.

64
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Sanofi and AstraZeneca to supply additional RSV doses to US

Pharmaceutical Technology

The US government is set to receive an additional 230,000 doses of RSV injection Beyfortus from Sanofi and AstraZeneca in January 2024.

article thumbnail

Moderate Intensity Exercise May Improve Cognition Following a Night of Poor Sleep

Pharmacy Times

Moderate cycling improved cognitive function in patients who got partial or no sleep.

article thumbnail

FDA approves US WorldMeds’s iwilfin for neuroblastoma

Pharmaceutical Technology

The US FDA granted approval for US WorldMeds’ iwilfin for use as an oral maintenance treatment for high-risk neuroblastoma.

FDA 59
article thumbnail

New filtering system to combat spread of infections in hospitals

PharmaTimes

The combined system works to detect and eliminate airborne pathogens A new air-filtering system developed by the University of Glasgow and Pinpoint Medical aims to detect and eliminate airborne pathogens to combat the spread of infections in hospitals. Funded by the UK Research and Innovations’ (UKRI) Engineering and Physical Sciences Research Council (EPSRC), the platform will decontaminate the air of pathogens and measure air quality to ensure a safer and healthier environment.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

National Vaccine Injury Compensation Program Aims to Address Vaccine Hesitancy

Pharmacy Times

The proposed Vaccine Injury Compensation Modernization Act is intended to bring valuable updates to the 36-year-old legislation.

55
article thumbnail

9 Best CRMs for Wholesalers

Spotio

The wholesale distribution industry is huge, measuring $10 trillion in the US alone. To put that number in context, the retail industry measures $5.63 trillion, the finance and insurance industry measures $4.97 trillion, and the construction industry measures 2.29 trillion. Obviously, wholesalers are a critical part of the economy, which is why there are so many businesses in this sector.

CRM 52
article thumbnail

Researchers Share Recommendations to Combat Health Misinformation Spread to Adolescents on Social Media

Pharmacy Times

The researchers emphasized that individuals must advocate for new policies that could aid regulation of harmful information being shared through social media platforms.

Media 52
article thumbnail

A lesson in behavioral economics: Driving value-based care through physician incentives

Clarify Health

Beyond Theory: Harnessing Incentives to Drive Value-Based Care Initiatives Healthcare Unbound episode recap: On this episode of the Healthcare Unbound podcast , behavioral economics expert Dr. Zeke Emanuel discusses how to create physician incentives to control costs and improve outcomes in healthcare. Physician incentives should be real, substantial, and timely to get the desired positive response from doctors and drive value-based care payment models.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A